MeSH Browser

MeSH Heading: 3',5'-Cyclic-AMP Phosphodiesterases
Tree Number(s): D08.811.277.352.640.150; D12.776.476.008
Unique ID: D015105
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D015105
Annotation: general or unspecified; prefer specifics
Scope Note: Enzymes that catalyze the hydrolysis of CYCLIC AMP to form adenosine 5'-phosphate. The enzymes are widely distributed in animal tissue and control the level of intracellular cyclic AMP. Many specific enzymes classified under this heading demonstrate additional spcificity for 3',5'-cyclic IMP and CYCLIC GMP.
Entry Term(s): 3',5' Cyclic AMP Phosphodiesterase; 3',5'-Cyclic AMP 5'-Nucleotidohydrolase; 3',5'-Cyclic AMP Phosphodiesterase; 3',5'-Cyclic Nucleotide Phosphodiesterase; 3',5'-Cyclic-AMP Phosphodiesterase; 3',5'-Cyclic-Nucleotide Phosphodiesterase; 3',5'-Nucleotide Phosphodiesterase; 3,5-Cyclic AMP 5-Nucleotidohydrolase; 3,5-Cyclic AMP Phosphodiesterase; CAMP Phosphodiesterase
CAS Type 1 Name: 3',5'-Cyclic-nucleotide 5'-nucleotidohydrolase
Previous Indexing: Adenosine Cyclic Monophosphate (1973-1974); Phosphodiesterases (1973-1974)
Public MeSH Note: 2008; see 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE 1994-2007, see 3',5'-CYCLIC AMP PHOSPHODIESTERASE 1975-1993, see PHOSPHODIESTERASES 1975-1977
History Note: 2008(1975)
Date Established: 1978/01/01
Date of Entry: 1974/11/11
Revision Date: 2021/05/20

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

3',5'-Cyclic-AMP Phosphodiesterases MeSH Descriptor Data 2025